Bio-Gene Technology (ASX:BGT) Other Current Payables: A$0.00 Mil (As of Dec. 2025)


What is Bio-Gene Technology Other Current Payables?

Bio-Gene Technology ASX:BGT Other Current Payables is A$0.00 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's Other Current Payables for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Bio-Gene Technology's quarterly Other Current Payables increased from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$0.23 Mil) but then declined from Jun. 2025 (A$0.23 Mil) to Dec. 2025 (A$0.00 Mil).

Bio-Gene Technology's annual Other Current Payables declined from Jun. 2023 (A$0.19 Mil) to Jun. 2024 (A$0.19 Mil) but then increased from Jun. 2024 (A$0.19 Mil) to Jun. 2025 (A$0.23 Mil).

Bio-Gene Technology Other Current Payables Related Terms

Bio-Gene Technology Other Current Payables Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Other Current Payables Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial 0.32 0.30 0.19 0.19 0.23

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.19 0.00 0.23 0.00

Bio-Gene Technology Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of A$0.00 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Other Current Payables of A$0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Other Current Payables too high?
Bio-Gene Technology's current Other Current Payables is A$0.00 Mil.
How does Bio-Gene Technology's Other Current Payables compare to VRTX and REGN?
Bio-Gene Technology's Other Current Payables of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Other Current Payables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Other Current Payables of A$0.00 Mil. The current Other Current Payables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Other Current Payables is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.